Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (103,639)	$ (4,809,088)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,380,004	$ 3,300,654
Gain on sale of asset	(163,333)
Stock-based compensation	2,009,742	$ 2,930,576
Loss on cumulative foreign currency translation adjustment	862,078
Bad debt expense (recovery)	(248,000)	$ 116,000
Amortization of discounts on notes payable and debt issuance costs	151,631	445,867
Revaluation of Warrant Liability	(6,212)	(82,471)
Changes in operating assets and liabilities:
Accounts receivable - trade	(1,676,482)	2,000,539
Prepaid expenses, other current assets, and other assets	(21,089)	(314,278)
Accounts payable and accrued expenses	(1,248,554)	(1,657,410)
Deferred revenue	(10,731)	(62,650)
Net cash provided by operating activities	1,925,415	1,867,739
Cash flows from investing activities:
Purchase of property and equipment	(1,297,237)	$ (590,385)
Proceeds from sale of asset	255,000
Net cash used in investing activities	$ (1,042,237)	$ (590,385)
Cash flows from financing activities:
Proceeds from issuance of common stock		$ 10,572,559
Proceeds from exercise of stock options	$ 10,747
Payments of capital leases	(732,729)	$ (702,164)
Payments on long-term debt	(1,529,760)	(1,851,413)
Net cash (used in) provided by financing activities	(2,251,742)	8,018,982
Effect of foreign currency exchange rate on cash	(144,203)	(28,902)
Net (decrease) increase in cash and cash equivalents	(1,512,767)	9,267,434
Cash and cash equivalents at beginning of the period	17,041,050	6,330,532
Cash and cash equivalents at end of period	15,528,283	15,597,966
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	$ 223,609	422,661
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Purchase of property and equipment through capital leases		167,354
Warrant exercise settlement		$ 174,891